<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03347851</url>
  </required_header>
  <id_info>
    <org_study_id>2017-1</org_study_id>
    <nct_id>NCT03347851</nct_id>
  </id_info>
  <brief_title>Post-surgical Aortic Hemodynamics After Aortic Valve Replacement</brief_title>
  <official_title>Investigation of Post-surgical Aortic Hemodynamics After Aortic Valve Replacement</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>CryoLife, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Northwestern University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>CryoLife, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this pilot study is to obtain both near valve and downstream flow
      characteristics, using 3D transthoracic echocardiography and 4D flow MRI respectively, in an
      existing patient population at Northwestern Memorial Hospital, to determine the hinge washout
      characteristics and downstream flow patterns of the On-X valve and compared to competing
      designs.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prospective, concurrent 4D flow Magnetic Resonance Imaging (MRI) and echocardiography of On-X
      and St Jude Medical (SJM) Masters HP or Carbomedics Carbo-seal or Carbo-seal Valsalva aortic
      valve replacement (AVR) patients will be performed. Echocardiography analysis will include:
      valve function (opening angle), pressure gradients, and degree of valve washout. MRI analysis
      will focus on downstream flow patterns (helicity and vorticity), energy loss, pressure
      recovery, and measurement of wall shear stress in the anastomosis regions.
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">October 26, 2017</start_date>
  <completion_date type="Anticipated">August 2018</completion_date>
  <primary_completion_date type="Anticipated">May 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Downstream flow patterns (helicity and vorticity)</measure>
    <time_frame>3 months</time_frame>
    <description>MRI data analysis; Helicity and vorticity graded (1-3) by blinded reviewers.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Hinge washout</measure>
    <time_frame>3 months</time_frame>
    <description>MRI data analysis; Yes/No</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Energy loss</measure>
    <time_frame>3 months</time_frame>
    <description>MRI data analysis; Irreversible energy loss quantified.Efforts will include the quantification of turbulent kinetic energy. This is representative of permanent pressure loss.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Wall shear stress (WSS)</measure>
    <time_frame>3 months</time_frame>
    <description>MRI data analysis; WSS, the tangential force exerted by blood flow on the vessel wall, measured in the anastomosis regions</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ejection Fraction (%)</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Primary EDV (ml)</measure>
    <time_frame>3 months</time_frame>
    <description>End Diastolic Volume</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Normalized EDV (ml/m^2)</measure>
    <time_frame>3 months</time_frame>
    <description>End Diastolic Volume</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Primary ESV (mL)</measure>
    <time_frame>3 months</time_frame>
    <description>End Systolic Volume</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Normalized ESV (mL/m^2)</measure>
    <time_frame>3 months</time_frame>
    <description>End Systolic Volume</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Peak Velocity (m/s)</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean velocity (m/s)</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Peak transvalvular pressure gradient (mmHg)</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean transvalvular pressure gradient (mmHg)</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effective Orifice Area (EOA)</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effective Orifice Area index (EOAi)</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Valve Heart Disease</condition>
  <arm_group>
    <arm_group_label>On-X AAP</arm_group_label>
    <description>Patients with prior AVR surgery with the CryoLife On-X Ascending Aortic Prosthesis (AAP).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SJM Masters or Carbomedics Carbo-seal</arm_group_label>
    <description>Patients with St. Jude Medical Masters HP Valved Graft with Gelweave Valsalvaâ„¢ Technology or Carbomedics Carbo-seal (including Carbo-seal Valsalva) mechanical aortic valve prostheses patients</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>MRI</intervention_name>
    <description>Enrolled patients will complete a non-contrast cardiac MRI</description>
    <arm_group_label>On-X AAP</arm_group_label>
    <arm_group_label>SJM Masters or Carbomedics Carbo-seal</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Transthoracic echocardiography exam</intervention_name>
    <description>Enrolled patients will complete a transthoracic echocardiography exam.</description>
    <arm_group_label>On-X AAP</arm_group_label>
    <arm_group_label>SJM Masters or Carbomedics Carbo-seal</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with aortic valve disease who within the last five years underwent AVR using the
        On-X aortic valve, SJM Masters HP, or Carbomedics aortic valves.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male and female subjects 18-89 years of age

          -  Patients with aortic valve disease who within the last five years underwent AVR using
             the On-X aortic valve, SJM Masters HP, or Carbomedics aortic valves.

        Exclusion Criteria:

          -  Patients contraindicated against MRI

          -  Patients with pacemakers, cochlear (in the ear) implants, or aneurysm clips or
             patients who have worked with metal

          -  Patients unwilling or unable to give written informed consent

          -  Pregnant women

          -  Prisoners

          -  Patients with an Effective Orifice Area index (EOAi) &lt;0.85 cm2/m2
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>89 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Northwestern University</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60208</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 24, 2017</study_first_submitted>
  <study_first_submitted_qc>November 15, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 20, 2017</study_first_posted>
  <last_update_submitted>November 30, 2017</last_update_submitted>
  <last_update_submitted_qc>November 30, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 4, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>mechanical heart valve</keyword>
  <keyword>On-X</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Heart Valve Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

